11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Clinical studies with work participation (WP) as an outcome domain pose particular methodological challenges that hamper interpretation, comparison between studies and meta-analyses.

          Objectives

          To develop Points to Consider (PtC) for design, analysis and reporting of studies of patients with inflammatory arthritis that include WP as a primary or secondary outcome domain.

          Methods

          The EULAR Standardised Operating Procedures were followed. A multidisciplinary taskforce with 22 experts including patients with rheumatic diseases, from 10 EULAR countries and Canada, identified methodologic areas of concern. Two systematic literature reviews (SLR) appraised the methodology across these areas. In parallel, two surveys among professional societies and experts outside the taskforce sought for additional methodological areas or existing conducting/reporting recommendations. The taskforce formulated the PtC after presentation of the SLRs and survey results, and discussion. Consensus was obtained through informal voting, with levels of agreement obtained anonymously.

          Results

          Two overarching principles and nine PtC were formulated. The taskforce recommends to align the work-related study objective to the design, duration, and outcome domains/measurement instruments of the study (PtC: 1–3); to identify contextual factors upfront and account for them in analyses (PtC: 4); to account for interdependence of different work outcome domains and for changes in work status over time (PtC: 5–7); to present results as means as well as proportions of patients reaching predefined meaningful categories (PtC: 8) and to explicitly report volumes of productivity loss when costs are an outcome (PtC:9).

          Conclusion

          Adherence to these EULAR PtC will improve the methodological quality of studies evaluating WP.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

          Much of biomedical research is observational. The reporting of such research is often inadequate, which hampers the assessment of its strengths and weaknesses and of a study's generalizability. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Initiative developed recommendations on what should be included in an accurate and complete report of an observational study. We defined the scope of the recommendations to cover three main study designs: cohort, case-control, and cross-sectional studies. We convened a 2-day workshop in September 2004, with methodologists, researchers, and journal editors to draft a checklist of items. This list was subsequently revised during several meetings of the coordinating group and in e-mail discussions with the larger group of STROBE contributors, taking into account empirical evidence and methodological considerations. The workshop and the subsequent iterative process of consultation and revision resulted in a checklist of 22 items (the STROBE Statement) that relate to the title, abstract, introduction, methods, results, and discussion sections of articles. Eighteen items are common to all three study designs and four are specific for cohort, case-control, or cross-sectional studies. A detailed Explanation and Elaboration document is published separately and is freely available on the web sites of PLoS Medicine, Annals of Internal Medicine, and Epidemiology. We hope that the STROBE Statement will contribute to improving the quality of reporting of observational studies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument

            The construct validity of a quantitative work productivity and activity impairment (WPAI) measure of health outcomes was tested for use in clinical trials, along with its reproducibility when administered by 2 different methods. 106 employed individuals affected by a health problem were randomised to receive either 2 self-administered questionnaires (self administration) or one self-administered questionnaire followed by a telephone interview (interviewer administration). Construct validity of the WPAI measures of time missed from work, impairment of work and regular activities due to overall health and symptoms, were assessed relative to measures of general health perceptions, role (physical), role (emotional), pain, symptom severity and global measures of work and interference with regular activity. Multivariate linear regression models were used to explain the variance in work productivity and regular activity by validation measures. Data generated by interviewer-administration of the WPAI had higher construct validity and fewer omissions than that obtained by self-administration of the instrument. All measures of work productivity and activity impairment were positively correlated with measures which had proven construct validity. These validation measures explained 54 to 64% of variance (p less than 0.0001) in productivity and activity impairment variables of the WPAI. Overall work productivity (health and symptom) was significantly related to general health perceptions and the global measures of interference with regular activity. The self-administered questionnaire had adequate reproducibility but less construct validity than interviewer administration. Both administration methods of the WPAI warrant further evaluation as a measure of morbidity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Guidance for Developers of Health Research Reporting Guidelines

              David Moher and colleagues from the EQUATOR network offer guidance and recommended steps for developing health research reporting guidelines.
                Bookmark

                Author and article information

                Journal
                Ann Rheum Dis
                Ann Rheum Dis
                annrheumdis
                ard
                Annals of the Rheumatic Diseases
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                0003-4967
                1468-2060
                September 2021
                8 April 2021
                : 80
                : 9
                : 1116-1123
                Affiliations
                [1 ]departmentDivision of Rheumatology , Maastricht University Medical Centre+ Internal Medicine , Maastricht, The Netherlands
                [2 ]Universiteit Maastricht Care and Public Health Research Institute , Maastricht, The Netherlands
                [3 ]departmentRheumatologist , Leiden University Medical Center , Leiden, The Netherlands
                [4 ]departmentRheumatology , Centro Hospitalar e Universitario de Coimbra EPE , Coimbra, Portugal
                [5 ]departmentRheumatology Unit , University of Perugia Department of Medicine , Perugia, Italy
                [6 ]departmentDepartment of Rheumatology, Instituto de Investigation Sanitaria San Carlos , Hospital Clinico Universitario San Carlos , Madrid, Spain
                [7 ]departmentMobility Program Clinical Research Unit , St Michael's Hospital Li Ka Shing Knowledge Institute , Toronto, Ontario, Canada
                [8 ]Neil Betteridge Associates , London, UK
                [9 ]departmentPain and Rehabilitation Center, and Department of Health, Medicine and Caring Sciences , Linköping University , Linkoping, Sweden
                [10 ]departmentDepartment of Epidemiology and Data Science; Amsterdam Rheumatology and Immunology Center , Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam , Amsterdam, The Netherlands
                [11 ]departmentPatients with Arthritis and Rheumatism (PARE) working group , European League Against Rheumatism , Zurich, Switzerland
                [12 ]departmentPEPITES teams , Pierre Louis Institute for Epidemiology and Public Health, Inserm UMR 1136 , Paris, France
                [13 ]departmentRheumatology Dept, Pitié Salpetriere Hospital , Sorbonne University / Assistance Publique- Hôpitaux de Paris , Paris, Fance
                [14 ]departmentAPEMAC , Université de Lorraine , Nancy, France
                [15 ]departmentCIC Epidémiologie Clinique , CHRU Nancy, Inserm, Université de Lorraine , Nancy, France
                [16 ]Portuguese League Against Rheumatic Diseases (LPCDR) and Comprehensive Health Research Centre (CHRC) , Lisbon, Portugal
                [17 ]departmentPeople with Arthritis and Rheumatism (PARE) , European League Against Rheumatism , Zurich, Switzerland
                [18 ]departmentCentre for Rheumatic Diseases , King’s College of London , London, UK
                [19 ]departmentRheumatology Department , King’s College Hospital , London, UK
                [20 ]departmentHealth Economics Research Center , University Research and Innovation Center, Óbuda University , Budapest, Hungary
                [21 ]departmentRheumatology Department , Centro Hospitalar de Lisboa Ocidental EPE Hospital de Egas Moniz , Lisboa, Portugal
                [22 ]NOVA Medical School , Lisboa, Portugal
                [23 ]departmentErasmus School of Health Policy & Management and iMTA, Institute for Medical Technology Assessment , Erasmus University Rotterdam , Rotterdam, The Netherlands
                [24 ]departmentCentre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health , The University of Manchester , Manchester, UK
                [25 ]departmentManchester University NHS Foundation Trust, Manchester Academic Health Science Centre , NIHR Manchester Biomedical Research Centre , Manchester, UK
                [26 ]departmentMRC Versus Arthritis Centre for Musculoskeletal Health and Work, MRC Life course Epidemiology Unit , Southampton General Hospital , Southampton, UK
                [27 ]departmentDepartment of Clinical sciences , Lund University , Lund, Sweden
                [28 ]departmentDepartment of Rheumatology , Skåne University Hospital , Lund, Sweden
                [29 ]departmentDepartment of Epidemiology and Data Science, Amsterdam Public Health , Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands
                [30 ]departmentDepartment of Rheumatology and immunology, AI&I , Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands
                [31 ]departmentDept of Rheumatology , KU Leuven University Hospitals Leuven , Leuven, Belgium
                [32 ]departmentSkeletal Biology and Engineering Research Centre , KU Leuven Department of Development and Regeneration , Leuven, Belgium
                [33 ]departmentRheumatology , Leiden University Medical Center , Leiden, The Netherlands
                [34 ]departmentRheumatology , Zuyderland Medical Centre Heerlen , Heerlen, The Netherlands
                Author notes
                [Correspondence to ] Dr Annelies Boonen, Dapt of Internal Medicine, Div of Rheumatology, Maastricht University Medical Centre+ Internal Medicine, Maastricht 6229 HX, The Netherlands; a.boonen@ 123456mumc.nl
                Author information
                http://orcid.org/0000-0003-0682-9533
                http://orcid.org/0000-0002-9342-1861
                http://orcid.org/0000-0003-1105-5640
                http://orcid.org/0000-0002-1607-187X
                http://orcid.org/0000-0002-6969-283X
                http://orcid.org/0000-0001-8845-4274
                http://orcid.org/0000-0001-6847-3726
                http://orcid.org/0000-0002-4915-2924
                http://orcid.org/0000-0002-3432-3073
                http://orcid.org/0000-0002-8899-9087
                Article
                annrheumdis-2020-219523
                10.1136/annrheumdis-2020-219523
                8372378
                33832966
                11111572-1170-4827-9d0f-39cf9275b31f
                © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 16 November 2020
                : 21 March 2021
                : 23 March 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100008741, European League Against Rheumatism;
                Award ID: EPI021
                Categories
                Recommendation
                1506
                2430
                2311
                Custom metadata
                unlocked

                Immunology
                outcome and process assessment,health care,arthritis,rheumatoid,spondylitis,ankylosing,psoriatic

                Comments

                Comment on this article